manage glp-1 side effects medications have changed the conversation around weight management, but they're not without effects. The most common concerns include nausea, constipation, fatigue, muscle loss and nutritional inadequacies—many of which can be GLP-1 Medications: Side Effects and

GLP-1 receptor agonists including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and a growing pipeline of new entrants are being prescribed to tens of millions of Americans for weight loss and diabetes management, and they are fundamentally altering how, when, and how much people eat

6.2 Potential pathophysiological mechanisms of gut microbiota and metabolite SCFAs in cytokine abnormalities SCFAs (such as acetate, propionate, and butyrate) activate receptors like FFAR2/3 and Gpr109a and inhibit histone deacetylase (HDAC), collectively suppressing the activation of the NF-B signaling pathway, thereby downregulating the expression of pro-inflammatory cytokines (202204)

N., Gregrio, J., Rodrigues, L

However, a systematic review of observational studies showed substantial heterogeneity in the results (Kirvalidze et al., 2022)

Subcutaneous injection is the most commonly referenced research format

Ozempic was approved by the U.S